Bausch + Lomb Corporation Launches as a Publicly Traded Company
Bausch + Lomb Corporation today launched as a publicly traded company focused on protecting and enhancing the gift of sight for millions of people around the world when it began trading under the “BLCO” symbol on the New York Stock Exchange and Toronto Stock Exchange.1
“Today marks a tremendous milestone for Bausch + Lomb and an important step forward on the path to an independent company focused on eye health,” said Joseph C. Papa, chairman and CEO of Bausch + Lomb. “Bausch + Lomb has long been associated with many of the most significant advances in eye health, and I am honored to work alongside our 12,000 global employees as we continue to focus on achieving our ongoing mission of helping people see better to live better all over the world.”
As a fully integrated eye health company, Bausch + Lomb offers a comprehensive portfolio of more than 400 products spanning contact lenses, lens and eye care products, ophthalmic pharmaceuticals, over-the-counter products, and ophthalmic surgical devices and instruments. Since its founding in 1853, Bausch + Lomb has been dedicated to advancing eye health for people all over the world, and has pioneered hundreds of innovations, including SofLens®, the first mass-produced soft contact lens. Bausch + Lomb’s current portfolio includes market-leading products, such as Biotrue® and renu® multipurpose solutions, Biotrue® ONEday daily disposable contact lenses, LUMIFY® redness reliever eye drops, PreserVision® AREDS 2 formula eye vitamin and mineral supplements, and VYZULTA® (latanoprostene bunod ophthalmic solution 0.024%).
Bausch + Lomb currently has projects in various stages of preclinical and clinical development, including new over-the-counter eye care products, contact lenses, innovative software and prescription medications for myopia management, next-generation cataract and LASIK surgical equipment, premium IOLs, investigational treatments for dry eye, and preservative-free formulations of a range of eye drops.